Luthringer Remy 13D and 13G filings for Minerva Neurosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 09:06 am Sale | 2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Luthringer Remy | 132,470 2.500% | -268,565 (-66.97%) | Filing |
| 2021-02-16 06:02 am Purchase | 2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Luthringer Remy | 401,035 7.500% | 53,023 (+15.24%) | Filing |
| 2020-02-12 5:22 pm Purchase | 2019-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Luthringer Remy | 348,012 6.800% | 47,810 (+15.93%) | Filing |